NNMT and obesity due to melanocortin 4 receptor deficiency: Furthermore, the use of inhibitors in treating metabolic disorders such as obesity and diabetes has been suggested via using small molecules such as JBSNF-000028 to inhibit NNMT activity, thereby improving glucose tolerance after treatment [69].